I am delighted to be presenting at the 2023 Ovarian Cancer Australia Symposium for health professionals in Sydney on the 5th of May. I will be presenting on “ Heterogeneity and Immunobiology of High-Grade Serous Ovarian Cancer”.    To register, see the li…lnkd.in/eC8Mh_W7

lnkd.in/epsCUYKv lnkd.in/eEYHrwHT

lnkd.in/ecCK5CvC lnkd.in/eTchXfWA

Genetics and anatomy sculpt immune-cell partners of ovarian cancer nature.com/articles/d41586-0… @CoukosGeorge

On behalf of all coauthors, I am happy to share our recent pre-print with the community. lnkd.in/ecu36FuG

Tumor Microenvironment Cellular Crosstalk Predicts Response to Adoptive TIL Therapy in Melanoma biorxiv.org/cgi/content/shor… #biorxiv_immuno

Just out in @NatureNV, @CoukosGeorge and Denarda Dangaj Laniti consider how data that reveal cellular, molecular and mutational landscape, as ovarian cancer tumours grow and spread, might aid efforts to develop new targeted therapies. @unil @chuv @Ludwig_Cancer

𝘑𝘜𝘚𝘛 𝘖𝘜𝘛: REVIEW of immunobiology of HGSOC. 🔖TILs 🔖Opportunities for immunotherapy 📑go.nature.com/3qJ1pOs By Lana Kandalaft, Denarda Dangaj & @CoukosGeorge. #CancerResearch @unil @CHUVLausanne @Ludwig_Cancer.